A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant
A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines
Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.
The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV
† Indicates status has not been verified in more than two years